Resistance mutation patterns in plasma and breast milk of HIV-infected women receiving highly-active antiretroviral therapy for mother-to-child transmission prevention [5]

AIDS

Volumn 21, Issue 17, 2007, Pages 2360-2362

  Andreotti, Mauro ^a   Guidotti, Giovanni ^a   Galluzzo, Clementina M ^a   Mancinelli, Sandro ^b   Germano, Paola ^c   Pirillo, Maria F ^a   Marazzi, Maria Cristina ^d   Vella, Stefano ^a   Palombi, Leonardo ^b   Giuliano, Marina ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c DREAM Program   (Italy)

^d LUMSA UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; NEVIRAPINE; STAVUDINE; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

BREAST MILK; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; FEMALE; GESTATIONAL AGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MOZAMBIQUE; PLASMA; PRIORITY JOURNAL; PUERPERIUM; RNA ANALYSIS; SEQUENCE ANALYSIS; STORAGE TEMPERATURE; ULTRAVIOLET RADIATION; VERTICAL TRANSMISSION; VIRUS MUTATION; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DISEASE TRANSMISSION, VERTICAL; FEMALE; GENES, MDR; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; MILK, HUMAN; MUTATION; RNA, VIRAL;

EID: 37349083119     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3282f190a6     Document Type: Letter

References (9)

1. Fawzi W, Msamanga G, Spiegelman D, Renjifo B, Bang H, Kapiga S, et al. Transmission of HIV-1 through breastfeeding among women in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr 2002; 31:331-338.
2. Miotti PG, Taha TE, Kumwenda NI, Broadhead R, Mtimavalye LA, Van der Hoeven L, et al. HIV transmission through breastfeeding: a study in Malawi. JAMA 1999; 282:744-749.
3. Gaillard P, Fowler MG, Dabis F, Coovadia H, van der Horst C, van Rompay K, et al. Use of antiretroviral drugs to prevent HIV-1 transmission through breast-feeding: from animal studies to randomized clinical trials. J Acquir Immune Defic Syndr 2004; 35:178-187.
4. Kilewo C, Karlsson K, Ngarina M, Massawe A, Lyamuya E, Msemo G, et al. Prevention of mother to child transmission of HIV-1 through breastfeeding by treating mohters prophylactically with triple antiretroviral therapy in Dar es Salaam, Tanzania - the MITRA Plus study [abstract TuAX101]. Program and Abstracts of the Fourth International AIDS Society Conference on HIV Treatment and Pathogenesis. Sydney: AIDS Society, 2007.
5. Arendt V, Ndimubanzi P, Vyankandondera J, Ndayisaba G, Muganda J, Courteille O, et al. AMATA study: effectiveness of antiretroviral therapy in breatsfeeding mothers to prevent postnatal vertical transmission in Rwanda [abstract TuAX102]. Program and Abstracts of the Fourth International AIDS Society Conference on HIV Treatment and Pathogenesis. Sydney: AIDS Society, 2007.
6. Giuliano M, Guidotti G, Andreotti M, Pirillo MF, Villani P, Liotta G, et al. Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load. A study within the Drug Resource Enhancement against AIDS and Malnutrition Program. J Acquir Immune Defic Syndr 2007; 44:286-291.
7. Lyons F, Coughlan S, Byrne C, Hopkins SM, Hall WW, Mulcahy FM. Emergence of antiretroviral resistance in HIV-positive women receiving combination antiretroviral therapy in pregnancy. AIDS 2005; 19:63-67.
8. Duran A, Losso MH, Salomon H, Harris DR, Pampuro S, Soto-Ramirez LE, et al. Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis. AIDS 2007; 21:199-205.
9. Lee EJ, Kantor R, Zijenah L, Sheldon W, Emel L, Mateta P, et al. Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine. J Infect Dis 2005; 192:1260-1264.